B

Bioatla Inc
NASDAQ:BCAB

Watchlist Manager
Bioatla Inc
NASDAQ:BCAB
Watchlist
Price: 1.71 USD -14.07% Market Closed
Market Cap: 82.7m USD
Have any thoughts about
Bioatla Inc?
Write Note

EV/OCF
Enterprise Value to OCF

-0.3
Current
-0
Median
6
Industry
Lower than median
Lower than industry value

Enterprise Value to Operating Cash Flow (EV/OCF) ratio is a valuation multiple that measures the value of a company, debt included, to the operating cash flow it generates.

EV/OCF
-0.3
=
Enterprise Value
26.2m USD
/
Operating Cash Flow
-85.1m USD
All Countries
Close
Market Cap EV/OCF
US
Bioatla Inc
NASDAQ:BCAB
82.7m USD -0.3
FR
Pharnext SCA
OTC:PNEXF
6T USD -236 774.4
US
Abbvie Inc
NYSE:ABBV
299.8B USD 21.3
US
Amgen Inc
NASDAQ:AMGN
159.1B USD 28.5
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
124.7B USD -125.3
US
Gilead Sciences Inc
NASDAQ:GILD
114.8B USD 10.9
US
Epizyme Inc
F:EPE
94.1B EUR -475.5
AU
CSL Ltd
ASX:CSL
133.9B AUD 34.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
86.2B USD 18.6
US
Seagen Inc
F:SGT
39.3B EUR -74.4
NL
argenx SE
XBRU:ARGX
32.6B EUR -126
 
US
B
Bioatla Inc
NASDAQ:BCAB
Average EV/OCF: 22.8
Negative Multiple: -0.3
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -236 774.4
US
Abbvie Inc
NYSE:ABBV
21.3
US
Amgen Inc
NASDAQ:AMGN
28.5
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -125.3
US
Gilead Sciences Inc
NASDAQ:GILD
10.9
US
E
Epizyme Inc
F:EPE
Negative Multiple: -475.5
AU
CSL Ltd
ASX:CSL
34.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.6
US
S
Seagen Inc
F:SGT
Negative Multiple: -74.4
NL
argenx SE
XBRU:ARGX
Negative Multiple: -126

EV/OCF Forward Multiples

Forward EV/OCF multiple is a version of the EV/OCF ratio that uses forecasted operating cash flow for the EV/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/OCF
N/A
2-Years Forward
EV/OCF
N/A
3-Years Forward
EV/OCF
N/A

See Also

Discover More